Etanercept | Infliximab | Adalimumab | Combined | |
RF positive | 219/241 (91) | 189/218 (87) | 54/62 (87) | 462/521 (89) |
Anti-CCP positive | 206/241 (86) | 177/218 (81) | 42/62 (68) | 425/521 (82) |
SE carriage | 184/225 (82) | 208/261 (80) | 40/49 (82) | 432/535 (81) |
PTPN22 carriage | 78/268 (29) | 93/287 (33) | 17/64 (27) | 188/619 (30) |
Values are n of positive/total available (% positive).